CDIO Logo

Cardio Diagnostics Holdings, Inc. (CDIO) 

NASDAQ
Market Cap
$24.93M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
344 of 950
Rank in Industry
208 of 543

Largest Insider Buys in Sector

CDIO Stock Price History Chart

CDIO Stock Performance

About Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

Insider Activity of Cardio Diagnostics Holdings, Inc.

Over the last 12 months, insiders at Cardio Diagnostics Holdings, Inc. have bought $49,763 and sold $0 worth of Cardio Diagnostics Holdings, Inc. stock.

On average, over the past 5 years, insiders at Cardio Diagnostics Holdings, Inc. have bought $45,044 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Dogan Meeshanthini (Chief Executive Officer) — $40,000. Dogan Timur (Chief Technology Officer) — $40,000. Philibert Robert (Chief Medical Officer) — $9,763.

The last purchase of 34,075 shares for transaction amount of $9,763 was made by Philibert Robert (Chief Medical Officer) on 2024‑09‑06.

List of Insider Buy and Sell Transactions, Cardio Diagnostics Holdings, Inc.

2024-09-06PurchaseChief Medical Officer
34,075
0.0794%
$0.29$9,763-2.24%
2024-09-06PurchaseChief Executive Officer
68,965
0.1627%
$0.29$20,000-2.24%
2024-09-06PurchaseChief Technology Officer
68,965
0.1627%
$0.29$20,000-2.24%
2023-12-31Purchasedirector
0
$0$0-80.62%
2023-09-30Purchasedirector
0
$0$0+113.99%
2023-09-30Purchasedirector
0
$0$0+113.99%
2023-08-31PurchaseChief Technology Officer
16,481
0.0731%
$0.55$8,982+32.28%
2023-08-31PurchaseChief Executive Officer
16,481
0.0731%
$0.55$8,982+32.28%
2023-08-28PurchaseChief Medical Officer
18,000
0.0878%
$0.60$10,795+31.81%
2023-08-25PurchaseChief Technology Officer
1,770
0.008%
$0.56$982+35.46%
2023-08-25PurchaseChief Executive Officer
1,770
0.008%
$0.56$982+35.46%
2023-08-24PurchaseChief Medical Officer
16,000
0.0781%
$0.60$9,600+23.52%

Insider Historical Profitability

31.8%
Philibert RobertChief Medical Officer
1683867
4.1639%
$0.6230+27.67%
Dogan MeeshanthiniChief Executive Officer
1655429
4.0936%
$0.6230+33.87%
Dogan TimurChief Technology Officer
197310
0.4879%
$0.6230+33.87%
Intrater Jamesdirector
0
0%
$0.6210
Levy Odeddirector
0
0%
$0.6220

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.